Instrumentos

Nombre Mnemo Bolsa de valores Volumen promedio Cotización Tipo
ANDROS PHARMACEUTICALS CO.,LTD 6917

Taipei Exchange

84 443 21,45 TWD Acción Andros Pharmaceuticals Co.,Ltd Acción

Insiders

Foto Andrés Conesa Labastida
Andrés Conesa Labastida

Andrés Conesa Labastida is currently the Chief Executive Officer & Director at Aerovías de México SA de CV since 2013.
He is also the Chief Executive Officer & Executive Director at Grupo Aeroméxico SAB de CV since 2005.
Additionally, he serves as the Chairman of SkyTeam Airline Alliance Management.
He is an Independent Director at Sempra since 2017.
Furthermore, he holds director positions at Aceites Superfinos SA de CV, Aeromexpress SA de CV, Latin American & Caribbean Air Transport Association, and Airline Passenger Experience Association, Inc. In the past, Dr. Conesa Labastida served as the Chairman of Cintra Concesiones de lnfraestructuras de Transportes SA from 2003 to 2005.
He was also the Chairman of Consorcio Aeromexico SAB de CV and International Consolidated Airlines Group SA. From 2008 to 2018, he was a Director-Governors Board at the International Air Transport Association.
He was a Proprietary Director at Genomma Lab Internacional SAB de CV in 2012.
Additionally, he served as an Independent Director at Infraestructura Energetica Nova SAB de CV from 2013 to 2017.
He also held a director position at the Mexican Stock Exchange.
Prior to his current and former positions, he was the General Director-Economic Policy at The Mexican Secretariat of Finance & Public Credit from 1998 to 2003.
Dr. Conesa Labastida holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the Instituto Tecnológico Autónomo de México.










No hay resultados para esta búsqueda

  1. Bolsa de valores
  2. Búsqueda avanzada
  3. Andr�s Conesa Labastida